Startups
N2 Biomedical provides nano-engineered surface treatment and coating services to the medical device OEM. We work with startup to tier 1 spine, orthopedic, vascular and dental companies around the world. Our proprietary processes and equipment have transformed millions of medical devices to last longer, fight infection, improve biocompatibility and offer durable aesthetics
Overview
Employees
11-50
Founded date
2013
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 22, 2021 | Berkshire Biomedical Raises $2.75 Million in Convertible Debt | DALLAS, Oct. 22, 2021 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or "the Company"), focused on developing drug delivery devices designed to accurately and precisely deliver oral liquid drugs only to th... |
| Sep 14, 2021 | Lightstone Ventures, a Biomedical Investor, Raises $375 Million | Lightstone Ventures has raised $375 million for its largest venture-capital fund, a pool that will enable it to place bigger bets on bio- and medical-technology startups in the U.S. and abroad. Lightstone, based in Boston and Menlo Park, Ca... |
| Feb 3, 2021 | Berkshire Biomedical Raises $3M in First Financing | Berkshire Biomedical, a Dallas, TX-based digital health company developing a virtual care and prescription drug management system, completed a $3m funding. The backers were not disclosed. The company intends to use the funds to continue to ... |
| Jan 14, 2021 | N2 Biomedical Announces The First Surgical Implant Of A Spinal Device Coated With The Company's Thin, Ion-Assisted Titanium Coating Technology | |
| Oct 2, 2020 | Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor | Funding Will Support Clinical Trials to Evaluate the Company’s Novel Treatment for Peripheral Artery Disease Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, announced... |
| Oct 1, 2020 | Alucent Biomedical : Announces $35 Million Series B Financing Led by a Multinational Strategic Investor | Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced the close of a $35 million Series B financing round led by a large multinational strategic investor an... |
| Jun 18, 2019 | Ampersand Capital Partners Recaps N2 Biomedical | N2 Biomedical, a leading provider of coating and surface treatment solutions to the medical device industry, announced today the majority recapitalization of the company by Ampersand Capital Partners. As part of the transaction N2 also anno... |
| Jun 18, 2019 | N2 Biomedical Receives Growth Equity Investment from Ampersand Capital Partners | N2 Biomedical, a Bedford, Mass.-based provider of coating and surface treatment solutions to the medical device industry, received a majority recapitalization by Ampersand Capital Partners. The amount of the deal was not disclosed. As part ... |
| Apr 24, 2012 | Arigos Biomedical Receives $350K Grant | Arigos Biomedical, an early-stage company that develops methods of cooling organs for long-term storage, received an up to $350k grant from the Thiel Foundation. The foundation awarded the funding through Breakout Labs, its new revolving fu... |
Show more
Reviews 0
FAQ about N2 Biomedical LLC
When was N2 Biomedical LLC founded?
N2 Biomedical LLC was founded in 2013.
What has the press written about N2 Biomedical LLC?
Parsers VC has collected 12 articles mentioning N2 Biomedical LLC, among them “Berkshire Biomedical Raises $2.75 Million in Convertible Debt” (Oct 22, 2021) and “Lightstone Ventures, a Biomedical Investor, Raises $375 Million” (Sep 14, 2021).
Is N2 Biomedical LLC still active?
Yes, N2 Biomedical LLC is active; its latest activity on Parsers VC dates from Apr 4, 2022.